Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Bupivacaine/Heparin/Oxytocin

Vaginal bleeding and drug exposure during delivery

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zamurovic M, et al. Pulmonary embolism during delivery - Treatment and outcome. Clinical and Experimental Obstetrics and Gynecology 42 : 833-834, No. 6, Jan 2015. Available from: URL: https://dx.doi.org/10.12891/ceog1983.2015 Zamurovic M, et al. Pulmonary embolism during delivery - Treatment and outcome. Clinical and Experimental Obstetrics and Gynecology 42 : 833-834, No. 6, Jan 2015. Available from: URL: https://dx.doi.org/10.12891/ceog1983.2015
Metadaten
Titel
Bupivacaine/Heparin/Oxytocin
Vaginal bleeding and drug exposure during delivery
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56021-6

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Apixaban/heparin

Case report

Misoprostol

Case report

Chlormethine